What is the recommended prophylaxis for hemicrania continua?

Hemicrania Continua Prophylaxis

Indomethacin is the definitive first-line prophylactic treatment for hemicrania continua, as absolute response to therapeutic doses of indomethacin is both the diagnostic criterion and the most effective treatment for this disorder. 1, 2

First-Line Treatment: Indomethacin

• Indomethacin remains the gold standard for hemicrania continua prophylaxis, with patients demonstrating an absolute response that distinguishes this disorder from other headache types 1, 2
• The typical therapeutic dose ranges from 25-300 mg daily, though most patients respond to 75-150 mg daily divided into 2-3 doses 2
• A trial of at least 2-3 weeks at therapeutic doses is required before concluding treatment failure 2
• The main limitation is gastrointestinal side effects, which occur in 25-50% of patients and may necessitate alternative treatments 3, 2

Common Pitfall to Avoid

Do not prematurely abandon indomethacin due to mild GI symptoms—consider adding a proton pump inhibitor or switching to sustained-release formulations before moving to alternatives 2

Second-Line Alternatives (When Indomethacin Fails or Is Not Tolerated)

When indomethacin cannot be used, the following alternatives have demonstrated efficacy in case series and small studies:

Other NSAIDs

• Acemethacin has shown effectiveness in three patients with fewer gastrointestinal adverse events compared to indomethacin 4
• Other COX-II inhibitors may provide benefit, though evidence is limited to case reports 2

Melatonin

• Melatonin 3-30 mg daily achieved complete pain freedom in approximately 18% of patients and partial relief (allowing 50-75% reduction in indomethacin dose) in an additional 27% of patients 5
• This represents a reasonable adjunctive strategy to reduce indomethacin exposure and associated morbidity, though it rarely replaces indomethacin entirely 5

OnabotulinumtoxinA

• OnabotulinumtoxinA using the PREEMPT protocol (155 units distributed across specific head and neck sites) produced ≥50% reduction in moderate-to-severe headache days in 56% of patients (5 of 9) 6
• Median duration of response was 11 weeks, requiring repeat injections every 3 months 6
• This represents a viable option for indomethacin-intolerant patients, though the evidence base is limited 6

Topiramate

• Topiramate 50-200 mg daily has shown effectiveness in isolated case reports, with some patients maintaining response for 6 months after drug withdrawal 3
• The evidence is weaker than for other alternatives, limited to case reports 3

Verapamil

• Verapamil has demonstrated efficacy in at least one case report when indomethacin response faded 7
• This calcium channel blocker may be considered when other options have failed, though evidence is extremely limited 7

Treatment Algorithm

1. Initiate indomethacin 25 mg three times daily with food, titrating up to 75-150 mg daily over 1-2 weeks 2
2. Add gastroprotection (proton pump inhibitor) if mild GI symptoms develop 2
3. If indomethacin fails or causes intolerable side effects:
   • First alternative: Add melatonin 3-30 mg at bedtime to reduce indomethacin requirements 5
   • Second alternative: Switch to acemethacin if available 4
   • Third alternative: OnabotulinumtoxinA (PREEMPT protocol) every 12 weeks 6
   • Fourth alternative: Topiramate 50-200 mg daily 3

Critical Diagnostic Consideration

• Absolute response to indomethacin is required for diagnosis—if a patient does not respond completely to therapeutic doses of indomethacin, reconsider the diagnosis of hemicrania continua 1, 2
• Higher indomethacin dose requirements do not necessarily indicate secondary pathology, as the syndrome and response pattern remain similar in primary versus secondary cases 2
• However, neuroimaging should be obtained in all new-onset cases to exclude secondary causes, particularly pituitary lesions, vascular malformations, and posterior fossa pathology 2